GSK Doc Says FDA Knew All Co. Did About Paxil Suicide Risk

A psychiatrist who helped prepare a GlaxoSmithKline PLC analysis of the suicide risk associated with Paxil told an Illinois federal jury Thursday that the drugmaker was not hiding anything from the...

Already a subscriber? Click here to view full article